Neuronetics Inc (NASDAQ: STIM)’s stock price has plunge by -1.68relation to previous closing price of 1.19. Nevertheless, the company has seen a 17.00% surge in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-20 that MALVERN, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team will present at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024. The Company is scheduled to present at 2:30pm Eastern Time the same day via webcast.
Is It Worth Investing in Neuronetics Inc (NASDAQ: STIM) Right Now?
Company’s 36-month beta value is 2.25.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for STIM is 28.01M, and currently, short sellers hold a 3.46% ratio of that floaft. The average trading volume of STIM on December 06, 2024 was 448.60K shares.
STIM’s Market Performance
STIM stock saw a decrease of 17.00% in the past week, with a monthly decline of -1.68% and a quarterly a decrease of 50.00%. The volatility ratio for the week is 9.76%, and the volatility levels for the last 30 days are 15.88% for Neuronetics Inc (STIM). The simple moving average for the past 20 days is 24.40% for STIM’s stock, with a -42.73% simple moving average for the past 200 days.
STIM Trading at 24.62% from the 50-Day Moving Average
After a stumble in the market that brought STIM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.92% of loss for the given period.
Volatility was left at 15.88%, however, over the last 30 days, the volatility rate increased by 9.76%, as shares surge +9.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +50.97% upper at present.
During the last 5 trading sessions, STIM rose by +17.76%, which changed the moving average for the period of 200-days by -64.10% in comparison to the 20-day moving average, which settled at $0.9409. In addition, Neuronetics Inc saw -59.66% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at STIM starting from Furlong Stephen, who sale 1,368 shares at the price of $0.82 back on Oct 08 ’24. After this action, Furlong Stephen now owns 497,408 shares of Neuronetics Inc, valued at $1,122 using the latest closing price.
MACAN WILLIAM ANDREW, the EVP, GC, CCO and CS of Neuronetics Inc, sale 1,541 shares at $0.82 during a trade that took place back on Oct 08 ’24, which means that MACAN WILLIAM ANDREW is holding 402,792 shares at $1,264 based on the most recent closing price.
Stock Fundamentals for STIM
Current profitability levels for the company are sitting at:
- -0.38 for the present operating margin
- 0.74 for the gross margin
The net margin for Neuronetics Inc stands at -0.5. The total capital return value is set at -0.48. Equity return is now at value -153.94, with -43.59 for asset returns.
Based on Neuronetics Inc (STIM), the company’s capital structure generated 0.83 points at debt to capital in total, while cash flow to debt ratio is standing at -0.43. The debt to equity ratio resting at 4.98. The interest coverage ratio of the stock is -3.73.
Currently, EBITDA for the company is -22.76 million with net debt to EBITDA at -1.18. When we switch over and look at the enterprise to sales, we see a ratio of 0.87. The receivables turnover for the company is 3.77for trailing twelve months and the total asset turnover is 0.98. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.16.
Conclusion
In a nutshell, Neuronetics Inc (STIM) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
